- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Undervalued Small Caps
Hong Kong Pharmaceuticals & Biotech Undervalued Small Caps
Results
3
1 new
Undervalued Small Caps
3 companies
Essex Bio-Technology
Market Cap: HK$2.5b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.45
7D
4.0%
1Y
63.6%
Medtide
Market Cap: HK$3.6b
A contract research, development, and manufacturing company, provides early-stage discovery, preclinical research, clinical development, and commercial-stage production services.
3880
HK$25.44
7D
-1.4%
1Y
n/a
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.5b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
New
3613
HK$9.00
7D
-0.4%
1Y
9.6%